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Jasmonates are plant lipidederived oxylipins that act as key signaling compounds in plant immunity,
germination, and development. Although some physiological activities of natural jasmonates in
mammalian cells have been investigated, their anti-inﬂammatory actions in mammalian cells remain
unclear. Here, we investigated whether jasmonates protect mouse microglial MG5 cells against lipo-
polysaccharide (LPS)einduced inﬂammation. Among the jasmonates tested, only 12-oxo-phytodienoic
acid (OPDA) suppressed LPS-induced expression of the typical inﬂammatory cytokines interleukin-6 and
tumor necrosis factor a. In addition, only OPDA reduced LPS-induced nitric oxide production through a
decrease in the level of inducible nitric oxide synthase. Further mechanistic studies showed that OPDA
suppressed neuroinﬂammation by inhibiting nuclear factor kB and p38 mitogen-activated protein kinase
signaling in LPS-activated MG5 cells. In addition, OPDA induced expression of suppressor of cytokine
signaling-1 (SOCS-1), a negative regulator of inﬂammation, in MG5 cells. Finally, we found that the
nuclear factor erythroid 2-related factor 2 signaling cascade induced by OPDA is not involved in the anti-
inﬂammatory effects of OPDA. These results demonstrate that OPDA inhibited LPS-induced cell inﬂam-
mation in mouse microglial cells via multiple pathways, including suppression of nuclear factor kB, in-
hibition of p38, and activation of SOCS-1 signaling.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Jasmonates are plant-derived oxylipins similar to mammalian
oxylipins such as prostaglandins and leukotrienes [1]. Jasmonates
are present universally in plants but not in animal systems and are
found in relatively high amounts in fruits and vegetables [2,3]. In
plants, jasmonates such as 12-oxo-phytodienoic acid (OPDA), jas-
monic acid (JA), methyl jasmonate (MeJA), jasmonoyl isoleucine
(JA-Ile), and 12-hydroxy-jasmonic acid (12-OH-JA) are ubiquitously
occurring signalingmolecules that function as important regulators
of plant immunity, germination, and development [4e6]. Although
physiological functions of jasmonates in plant cells have been
extensively studied, studies on their action for mammalian cells are
still limited. The anti-cancer properties of MeJA and the anti-echnology, Tokyo Institute of
kohama 226-8501, Japan.
.
Inc. This is an open access article uoxidative effects of OPDA have been reported in mammalian cells
[7,8]. Some synthetic jasmonate analogs are also reported to have
anti-inﬂammatory activity in mammalian macrophages [9]. How-
ever, little is known about the effects of natural jasmonates against
inﬂammation in microglia.
In mammals, microglia are the resident innate immune cells in
the brain that play a major role in host defense and tissue repair in
the central nerve system [10]. They become overactive in response
to environmental stress and exposure to stimuli such as lipopoly-
saccharides (LPS) [10]. Overactivated microglia release pro-
inﬂammatory and neurotoxic factorsdincluding interleukin 6 (IL-
6), tumor necrosis factor a (TNF-a), and nitric oxide (NO)dthat are
involved in various neurodegenerative diseases such as Parkinson's
disease, Alzheimer's disease, cerebral ischemia, and multiple scle-
rosis [10,11]. Therefore, regulating the inﬂammatory molecules
released by abnormally activated microglia may provide a means
for treatment of neuroinﬂammatory diseases.
Nuclear factor kB (NF-kB) is an important transcription factor
involved in regulating the expression of various genes related tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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plasm by binding inhibitory subunit of NF-kB a (IkBa). Once acti-
vated by stimulants such as LPS, IkB kinase (IKK) phosphorylates
IkBa, leading to its proteasomal degradation. IkBa degradation re-
leases and activates NF-kB, which is translocated from the cytosol
to the nucleus, where it binds speciﬁc promoter regions of target
genes and induces transcription of pro-inﬂammatory and neuro-
toxic mediators such as IL-6, TNF-a, and inducible nitric oxide
synthase (iNOS) [12,13].
Mitogen-activated protein kinases (MAPKs), including p38, JNK,
and ERK, are a family of serine/threonine protein kinases that
regulate inﬂammatory and immune responses involved in LPS-
induced gene expression [14]. Increased MAPK activity is a critical
regulator of pro-inﬂammatory and neurotoxic factors in neurode-
generative processes [14,15]. Proteins of the suppressor of cytokine
signaling (SOCS) family are endogenous negative regulators of
cytokine signaling and pro-inﬂammatory cytokine expression [16].
SOCS can suppress cytokine signaling in vitro and in vivo [16,17],
and thus the SOCS family is considered an important regulator of
normal immune physiology and immune disease.
Nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription
factor that regulates transcription of phase II and other enzymes
that reduce oxidative stress, inhibits inﬂammatory responses in the
brain [18]. Furthermore, one of its target genes, heme oxygenase 1
(HO-1), suppresses LPS-induced inﬂammation [18]. We previously
reported that OPDA induced Nrf2 activation and subsequent
expression of antioxidants and phase II detoxiﬁcation enzymes
involving HO-1 [8]. We also showed that OPDA suppressed oxida-
tive stresseinduced cell death via the Nrf2 pathway in human
neurons [8]. Chronic inﬂammation and oxidative stress in microglia
and neurons have been implicated in various neurodegenerative
diseases, such as Parkinson's disease, Alzheimer's disease, and
multiple sclerosis [10,11,19]. Thus, compounds that have both anti-
oxidative and anti-inﬂammatory effects may be attractive for
therapy.
The effects of natural jasmonates against inﬂammation in
microglia cells are unclear. We therefore investigated the anti-
inﬂammatory effects of jasmonates and the mechanism of their
activities against LPS-induced pro-inﬂammatory responses in
mouse microglial MG5 cells. We show that, among jasmonates,
only OPDA inhibited inﬂammatory responses by suppressing the
NF-kB and p38 MAPK pathways and by activating SOCS-1 signaling,
each of which was independent of the Nrf2 pathway. Taken
together our results indicate that OPDA may be useful for the
treatment of neurodegenerative diseases.
2. Materials and methods
2.1. Materials
Dulbecco's modiﬁed Eagle medium (DMEM) and Lipofectamine
RNAiMAX were obtained from Life Technologies. Fetal bovine
serumwas obtained from Cell Culture Bioscience. cis-OPDA, (±)-JA,
and (±)-MeJAwere obtained from Cayman Chemical. ()-JA-Ile and
(±)-12-OH-JA were purchased from OlchemIm. Antibodies against
Nrf2, lamin, HO-1, and b-actin were obtained from Santa Cruz
Biotechnology, Biomol, and Abcam, respectively. Antiephospho
p65, anti-p65, anti-IkBa, anti-phospho JNK, anti-JNK, anti-phospho
p38, and anti-p38 were obtained from Cell Signaling. Horseradish
peroxidaseeconjugated secondary antibodies were from GE
Healthcare. NE-PER Nuclear and Cytoplasmic Extraction Reagent
and the Micro BCA Protein Assay kit were from Pierce. Chemi-Lumi
One Super was obtained from Nacalai. LPS, protease inhibitor
cocktail, and phosphatase inhibitor cocktail were purchased from
Sigma. All Stars Negative Control siRNA was obtained from Qiagen.The Maxwell 16 RNA puriﬁcation kit was from Promega. ReverTra
Ace and PVDF Blocking Reagent for Can Get Signal were from
Toyobo. The nitric oxide assay kit, Mouse IL-6 Quantikine ELISA kit,
and Mouse TNF-a Quantikine ELISA kit were purchased from R&D
Systems.2.2. Cell culture
Mouse microglial MG5 cells (JCRB Cell Bank, catalog number:
IFO50520) were grown in DMEM with 10% fetal bovine serum and
A1 (IFO50519)econditioned medium. Cells were maintained at
37 C in a humidiﬁed atmosphere with 5% CO2. Cells were plated at
the appropriate density and treated with various jasmonate con-
centrations (7.5, 15, and 30 mM) for various times (6 and 24 h).
Control cells were treated with medium lacking jasmonates. For
LPS treatment, cells were pretreated with each of several jasmo-
nates for 24 h, the medium was replaced with fresh medium
without jasmonates, and the cells were exposed to 1 mg/mL LPS for
various times (30 min, 3 h, and 24 h). Control cells were treated
with medium without jasmonates or LPS.2.3. Immunoblotting
Cells were solubilized using NE-PER Nuclear and Cytoplasmic
Extraction Reagent or RIPA buffer with 1% protease inhibitor
cocktail and 1% phosphatase inhibitor cocktail for nuclear protein
extraction or whole-cell protein extraction, respectively. Protein
concentrations were determined using theMicro BCA Protein Assay
kit. Proteins were subjected to SDS-PAGE and subsequently trans-
ferred to a polyvinylidene diﬂuoride membrane. The membranes
were blocked with PVDF Blocking Reagent for Can Get Signal and
incubated overnight at 4 C with primary antibodies against Nrf2,
lamin, HO-1, phospho p65, p65, IkBa, phospho JNK, JNK, phospho
p38, p38, or b-actin. Each membrane was washed in phosphate-
buffered saline containing 0.1% (v/v) Tween-20 and incubated for
1 h at room temperature with horseradish peroxidaseeconjugated
secondary antibody. Chemiluminescent signals generated by
Chemi-Lumi One Super reagent were detected with the Image
Quant LAS 3000 CCD camera system (Fujiﬁlm).2.4. Quantitative real-time PCR analysis
Total RNA was extracted using the Maxwell RNA puriﬁcation
system, which includes a DNase step, and then cDNA was synthe-
sized using random hexamer primers and ReverTra Ace reverse
transcriptase. Quantitative real-time PCR was performed using the
7500HT Fast Real-Time PCR system (Applied Biosystems). TaqMan
Gene Expression Assay kits for IL-6 (Mm00446190), TNF-a
(Mm00443260), iNOS (Mm00440502), and SOCS-1
(Mm00782550) were used. Data were normalized to GAPDH
mRNA, which was ampliﬁed and detected using the following
primers and probes (50e30): forward primer, CAAATTCAACGGCA-
CAGTCAAG; reverse primer, CCTCACCCCATTTGATGTTAGTG; probe
(FAM-TAMRA), CCATCACCATCTTCCAGGAGCGAGAC.2.5. Measurement of cytokines and NO
Levels of cytokines in culture supernatants were measured us-
ing Quantikine ELISA kits according to manufacturer's instructions.
Generation of NO was determined by measuring accumulation of
nitrite (a stable end product of NO) in the medium using a nitric
oxide assay kit.
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MG5 cells were transiently transfected with Nrf2 siRNA (50-
AACTCTCAAGTTAATTTCTTA-30) or All Stars Negative Control siRNA
using Lipofectamine RNAiMAX.
3. Results
3.1. OPDA decreases LPS-induced inﬂammatory responses
We ﬁrst examined the effects of OPDA, JA, MeJA, JA-Ile, and 12-
OH-JA on LPS-induced inﬂammatory activation inmouse microglial
MG5 cells. Cells were pretreated with jasmonates for 24 h and
exposed to LPS for an additional 3 h (Fig. 1). LPS treatment signif-
icantly increased mRNA expression of the pro-inﬂammatory cyto-
kines IL-6 and TNF-a, as well as iNOS, which produces NO.
Pretreatment with OPDA signiﬁcantly reduced LPS-induced mRNA
expression of IL-6, TNF-a, and iNOS in a concentration-dependent
manner (Fig. 1). No other jasmonate showed any anti-
inﬂammatory effect. These results indicated that, among jasmo-
nates, OPDA has unique properties that protect MG5 cells against
inﬂammation induced by LPS.
In a parallel experiment, we analyzed the effects of OPDA on IL-
6, TNF-a, and NO production following LPS treatment. Cells were
pretreated with OPDA for 24 h and exposed to LPS for an additional
24 h (Fig. 2). IL-6 and TNF-a protein and NO levels wereFig. 1. OPDA decreases LPS-induced IL-6, TNF-a, and iNOS mRNA expression. MG5 cells were
After the medium was changed, cells were exposed to 1 mg/mL LPS for 3 h. IL-6 (A), TNF-a (
were normalized to jasmonate-untreated, LPS-stimulated cells (100%). Values indicate mea
*p < 0.05 and **p < 0.01 versus LPS alone.signiﬁcantly increased in the culture medium of control LPS-
stimulated MG5 cells. However, pretreatment with OPDA resulted
in a signiﬁcant decrease in all three levels in a concentration-
dependent manner (Fig. 2). These results suggested that OPDA is
effective in suppressing production of pro-inﬂammatory and
neurotoxic mediators in activated microglia by altering transcrip-
tion of genes encoding IL-6, TNF-a, and iNOS.
3.2. OPDA suppresses LPS-induced activation of NF-kB and p38
MAPK and induces SOCS-1 transcription
NF-kB, a heterodimer of p65 and p50, is the most important
transcription factor involved in the regulation of pro-inﬂammatory
and neurotoxic mediators, including IL-6, TNF-a, and iNOS, in
activated microglial cells. Therefore, we investigated whether
OPDA is involved in NF-kB signaling pathway. A critical early step in
NF-kB activation is the degradation of the inhibitory protein IkBa.
As shown in Fig. 3A, IkBa was markedly degraded at 30 min after
LPS treatment, but this LPS-induced IkBa degradation was sup-
pressed by OPDA. Phosphorylation of p65 is also important for
enhanced NF-kB-mediated transactivation.We observed that OPDA
also suppressed LPS-induced phosphorylation of p65 (Fig. 3A).
These ﬁndings indicated that OPDA suppresses IL-6, TNF-a, and
iNOS expression at least in part through an NF-kB-dependent
mechanism.
To investigate other mechanisms responsible for the inhibitorypretreated with 7.5, 15, or 30 mM OPDA or 30 mM JA, MeJA, JA-Ile, or 12-OH-JA for 24 h.
B), and iNOS (C) mRNA levels were determined by quantitative real-time PCR. All data
n ± S.E.M. from three separate experiments. ##p < 0.01 versus unstimulated control;
Fig. 2. OPDA attenuates LPS-induced production of IL-6, TNF-a, and NO. MG5 cells were pretreated with 7.5, 15, or 30 mM OPDA for 24 h. After the medium was changed, cells were
exposed to 1 mg/mL LPS for 24 h. IL-6 (A), TNF-a (B) and NO (C) levels in the medium were determined. All data were normalized to OPDA-untreated, LPS-stimulated cells (100%).
Values indicate mean ± S.E.M. from three separate experiments. ##p < 0.01 versus unstimulated control; *p < 0.05 and **p < 0.01 versus LPS alone.
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on MAPK signaling. It is well known that LPS-mediated stimulation
of the pro-inﬂammatory reaction in immune cells involves activa-
tion of MAPK signaling pathways. Cells were pretreated with OPDA
for 24 h and then stimulated with LPS for 30 min. The phosphor-
ylation of p38 and JNK was increased by LPS stimulation. OPDA
reduced LPS-induced phosphorylation of p38, but had no effect on
phosphorylation of JNK (Fig. 3B). These results indicated that the
suppressed phosphorylation of p38 may contribute to the inhibi-
tory effect of OPDA on LPS-induced pro-inﬂammatory responses in
MG5 cells.
The SOCS family represents an important endogenous negative
regulatory mechanism of cytokine signaling that also affects pro-
inﬂammatory cytokine expression. We investigated whether
OPDA altered mRNA expression of SOCS-1 in MG5 cells. After 24 h
treatment with OPDA, the level of SOCS-1 transcript was signiﬁ-
cantly elevated (Fig. 3C), suggesting that SOCS-1 may mediate the
anti-inﬂammatory action of OPDA.
3.3. The Nrf2 pathway is activated by OPDA but is not involved in
OPDA-mediated anti-inﬂammatory responses
Because Nrf2 signaling regulates cellular anti-inﬂammatory re-
sponses, we examined whether OPDA protects cells from LPS-
induced inﬂammation by activating Nrf2 signaling pathway. First,
we examined the effect of OPDA on the intracellular localization of
Nrf2 in MG5 cells. We found that OPDA treatment increased
expression of Nrf2 protein in nuclear extracts (Fig. 4A). Further-
more, after treatment with OPDA, we observed elevated expression
of HO-1 protein, encoded by one of the target genes for Nrf2
(Fig. 4B).
To investigate whether Nrf2 signaling contributes to thesuppressive effects of OPDA on LPS-induced inﬂammation, we
transiently transfected MG5 cells with Nrf2 siRNA and evaluated
protein levels for Nrf2 and HO-1, as well as LPS-induced mRNA
expression for IL-6, TNF-a, and iNOS. Nrf2 siRNA reduced the OPDA-
induced nuclear translocation of Nrf2 and upregulation of HO-1
(Fig. 4A, B). However, OPDA-induced anti-inﬂammatory responses
against LPS were not suppressed by Nrf2 knockdown (Fig. 4C).
These data suggested that Nrf2 activation and the subsequent
upregulation of Nrf2 target genes are not involved in the anti-
inﬂammatory properties of OPDA.
4. Discussion
Neuroinﬂammation and oxidative stress are critical components
in the pathogenesis of neurodegenerative diseases [10]. Under
these pathological conditions, microglia become activated,
inducing the release of various pro-inﬂammatory and neurotoxic
mediators that are involved in the response to neuronal injury
[10,20]. In this regard, the inhibition of a variety of pro-
inﬂammatory and neurotoxic factors may provide an effective
therapeutic approach against neuroinﬂammatory diseases.
TNF-a and IL-6 are produced by activated microglia and play a
central role in initiating and regulating the cytokine cascade during
brain inﬂammation [21]. Here, we showed that OPDA inhibited the
production of these cytokines following LPS-activated inﬂamma-
tion in microglial MG5 cells. In the brain, NO is mainly produced by
microglia through activation of iNOS, and accumulation of NO is
toxic to neurons as oxidative stress [22]. In this study, we demon-
strated that OPDA prevents NO production in LPS-activated
microglia by inhibiting iNOS expression.
Next, we investigated the mechanism of the anti-inﬂammatory
effects of OPDA. We demonstrated that OPDA suppressed LPS-
Fig. 3. OPDA is involved in suppression of LPS-induced NF-kB and p38MAPK activation and induction of SOCS-1 expression. (A, B) MG5 cells were pretreated with 15 or 30 mMOPDA
for 24 h followed by stimulation with 1 mg/mL LPS for 30 min. IkBa, phospho p65, phospho p38, and phospho JNK protein levels were determined by immunoblotting. b-actin, p65,
p38, and JNK were used as loading controls. Immunoblots are representative of at least two independent experiments. (C) MG5 cells were treated with 30 mMOPDA for 24 h. SOCS-1
mRNA level was determined by quantitative real-time PCR. Values (mean ± S.E.M., n ¼ 3) are expressed as percent relative to untreated cells at 100%. **p < 0.01 versus control.
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ylation of IkBa by IKK, which results in targeted degradation of IkBa
and subsequent induction of NF-kB-regulated expression of in-
ﬂammatory and neurotoxic genes such as IL-6, TNFa, and iNOS
[12,13]. The structure of OPDA is similar to that of 15-deoxy-D-12,14-
prostaglandin J2 (15d-PGJ2), a mammalian prostaglandin that has a
cyclopentenone ring with an electrophilic carbon that can react
covalently by the Michael addition reaction with cysteine residues
in cellular proteins [23]. 15d-PGJ2 directly inhibits NF-kB-depen-
dent gene expression through covalent modiﬁcation of critical
cysteine residues in IKK and the DNA-binding domains of NF-kB
subunits [23]. The mechanism by which OPDA inhibits NF-kB
signaling might be similar to that of 15d-PGJ2, i.e., owing to their
structural similarity. This is consistent with the ﬁnding that none of
the other jasmonates, which are not electrophiles, could repress
NF-kB-dependent gene expression. In addition, the non-natural
MeJA analog methyl 4,5-dehydrojasmonate, which contains a
cyclopentenone ring, inhibits production of IL-6, TNF-a, and NO in
LPS-activated macrophages [9]. Thus, the cyclopentenone ring may
be important for the observed anti-inﬂammatory effects.
We showed that OPDA suppressed LPS-activated p38 but not
JNK. MAP kinases play a crucial role in controlling signaling events
that contribute to the production of neuroinﬂammatory mediators
[14]. In particular, the p38 MAPK has been strongly linked to neu-
roinﬂammation. Microglia from p38-deﬁcient mice have a dimin-
ished cytokine response to LPS [24]. In addition, the p38 inhibitor
decreases production of pro-inﬂammatory cytokines in the brainand attenuates neuronal damage in the neurodegenerative mouse
model [25]. Although the mechanism is unknown, the inhibition of
p38 by OPDA would be important for anti-inﬂammation in MG5
cells.
Macrophages from SOCS-1-deﬁcient mice are hypersensitive to
LPS signaling, resulting in overproduction of TNF-a and IL-6 [17].
Furthermore, overexpression of SOCS-1 inhibits LPS-induced IL-6
secretion by blocking JAK-STAT activation in macrophages [26].
Thus, induction of SOCS-1 expression by OPDA treatment may be
related to anti-inﬂammatory effects.
15d-PGJ2, which is structurally similar to OPDA, inhibits the
production of inﬂammatory mediators and cytokines in activated
microglia [27]. In addition, 15d-PGJ2 suppresses p38 activity and
induces SOCS-1 expression in microglia [28,29]. Moreover, 15-PGJ2
attenuates microglial inﬂammation and shows protective effects in
animal models of neuroinﬂammatory diseases such as brain
ischemia, multiple sclerosis, and spinal cord injury [30,31]. Given
the similar chemical structures and physiological activities of 15-
PGJ2 and OPDA, it is possible that OPDA will be effective for treat-
ment of neuroinﬂammatory diseases.
Our study demonstrates that OPDA inhibits production of LPS-
induced inﬂammatory mediators and cytokines via multiple path-
ways, including inhibition of NF-kB and p38 and activation of SOCS-
1 signaling, in microglial MG5 cells. OPDA also activated the Nrf2
pathway inmicroglial MG5 cells. Although, the contribution of Nrf2
activation to anti-inﬂammatory effects in microglia was small, we
previously reported that OPDA rescued neuronal cells from
Fig. 4. Nrf2 pathway activation by OPDA is not involved in anti-inﬂammatory responses. (A) MG5 cells were transiently transfected with negative control siRNA (NC) or Nrf2 siRNA
for 48 h, followed by treatment with 30 mM OPDA for 6 h. Nuclear Nrf2 was detected by immunoblotting. Lamin was used as a loading control. (B) Cells were transiently transfected
with NC or Nrf2 siRNA for 48 h and then treated with 30 mM OPDA for 24 h. HO-1 was measured by immunoblotting. b-actin was used as a loading control. Immunoblots are
representative of at least two independent experiments. (C) Cells were transiently transfected with NC or Nrf2 siRNA for 48 h, followed by treatment with 30 mM OPDA for 24 h.
After the medium was changed, cells were exposed to LPS for an additional 3 h. IL-6, TNF-a, and iNOS mRNA levels were determined by quantitative real-time PCR. All data were
normalized to OPDA-untreated, LPS-stimulated cells (100%). Values indicate mean ± S.E.M. from three separate experiments. n.s. indicates no signiﬁcance (p > 0.05) versus NC
siRNA.
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defense via activation of the Nrf2 pathway [8]. In neurodegenera-
tive diseases, activatedmicroglia can damage neurons by producing
pro-inﬂammatory factors involving TNF-a and oxidative stress
stimuli such as NO. The microglia would then become activated in
response to factors released from damaged neurons, inducing
toxicity in neighboring neurons and resulting in a self-amplifying
cycle of inﬂammation/oxidative stressemediated neuro-
degeneration [10,11,19]. Therefore, OPDA, which has both anti-
inﬂammatory and antioxidative effects, may be a possible thera-
peutic compound for treatment of inﬂammatory- and oxidative
stresserelated diseases, including neurodegenerative disorders.
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